# A Study to Accelerate Immune System Recovery Following Stem Cell Transplantation

> **NCT00429039** · PHASE2 · TERMINATED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University** · enrollment: 21 (actual)

## Conditions studied

- ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

## Interventions

- **DRUG:** L-leucyl-L-leucine methyl ester (LLME)

## Key facts

- **NCT ID:** NCT00429039
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2000-09
- **Primary completion:** 2007-10
- **Final completion:** 2009-08
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** Low accrual.
- **Last updated:** 2016-10-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00429039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00429039, "A Study to Accelerate Immune System Recovery Following Stem Cell Transplantation". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT00429039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*